[1] [3] The mechanism of action of semaglutide involves binding to GLP-1 receptors found throughout the body, particularly in the pancreas, gastrointestinal tract, and brain
Airdyne.00:31:12 Revisiting MDMA and psychedelics.00:48:06 Inducing plasticity is only half the job.00:53:17 The one-day protocol that cut my anxiety by 90%.01:00:27 Cortisol as the master key.01:03:26 Peptides demystified: GLP-1s, growth hormone, and BPC-157.01:14:44 The Enhanced Games, the Deca burrito, and the honesty problem.01:17:56 Pinealon, epitalon, and the hunt for more REM sleep.01:25:02 Why women, not gym bros, are the real peptide market.01:35:52 Why "no reported side effects" is a trap.01:43:48 Stem cells, cartilage regrowth, and mining the body for medicine.01:46:37 AI, wearables, and the race to write to the nervous system.01:54:12 The MIT mask that puts you to sleep in six minutes.01:56:09 Inside Andrew's new operating manual, Protocols.02:03:30 Navigating grief and remapping loss.02:04:40 Shut up, suit up, show up.02:08:03 Parting thoughts.*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tims email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tims books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferrissInstagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferrissLinkedIn: linkedin.com/in/timferrissSee Privacy Policy at and California Privacy Notice at
Novo Nordisk has acknowledged joint pain reports to the FDA, though causality remains unclear
Am J Physiol Endocrinol Metab 294(5):E846E852 Chedid V, Vijayvargiya P, Carlson P, Van Malderen K, Acosta A, Zinsmeister A et al (2018) Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: a pilot pharmacogenetics study
doi: 10.1152/ajpregu.00520.2015 29 Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, LIR and exendin-4
Two key enzymes are implicated in PUFA-PE synthesis, including acyl-CoA synthetase long-chain family member 4 (ACSL4) and lysophosphatidylcholine acyltransferase 3 (LPCAT3) [75]
